Table 2.
Correlations between SPOCK1 Expression and other important clinicopathological parameters in urothelial carcinomas.
Parameter | Category | Upper Urinary Tract Urothelial Carcinoma | Urinary Bladder Urothelial Carcinoma | ||||||
---|---|---|---|---|---|---|---|---|---|
Case No. | SPOCK1 Expression | P value | Case No. | SPOCK1 Expression | P value | ||||
Low | High | Low | High | ||||||
Gender& | Male | 158 | 82 | 76 | 0.514 | 216 | 105 | 111 | 0.489 |
Female | 182 | 88 | 94 | 79 | 42 | 37 | |||
Age (years)# | 340 | 65.16±10.91 | 66.00±8.76 | 0.961 | 295 | 65.27±13.02 | 66.81±11.35 | 0.543 | |
Tumor location& | Renal pelvis | 141 | 66 | 75 | 0.194 | - | - | - | - |
Ureter | 150 | 83 | 67 | - | - | - | - | ||
Renal pelvis & ureter | 49 | 21 | 28 | - | - | - | - | ||
Multifocality& | Single | 278 | 143 | 135 | 0.261 | - | - | - | - |
Multifocal | 62 | 27 | 35 | - | - | - | - | ||
Primary tumor (T) & | Ta | 89 | 61 | 28 | <0.001* | 84 | 70 | 14 | <0.001* |
T1 | 92 | 57 | 35 | 88 | 42 | 46 | |||
T2-T4 | 159 | 52 | 107 | 123 | 35 | 88 | |||
Nodal metastasis& | Negative (N0) | 312 | 163 | 149 | 0.006* | 266 | 138 | 128 | 0.033* |
Positive (N1-N2) | 28 | 7 | 21 | 29 | 9 | 20 | |||
Histological grade & | Low grade | 56 | 41 | 15 | <0.001* | 56 | 46 | 10 | <0.001* |
High grade | 284 | 129 | 155 | 239 | 101 | 138 | |||
Vascular invasion& | Absent | 234 | 148 | 86 | <0.001* | 246 | 140 | 106 | <0.001* |
Present | 106 | 22 | 84 | 49 | 7 | 42 | |||
Perineural invasion& | Absent | 321 | 169 | 152 | <0.001* | 275 | 144 | 131 | 0.001* |
Present | 19 | 1 | 18 | 20 | 3 | 17 | |||
Mitotic rate (per 10 high power fields)# | 340 | 10.63±12.07 | 13.99±12.30 | <0.001* | 295 | 12.41±13.89 | 16.39±13.95 | 0.001* |
&, Chi-Square test; #, Mann-Whitney U test; * Statistically significant.